Association of Vitamin C with Enhanced Prognosis in Patients Experiencing Myocardial Injury Due to Sepsis: Findings from the MIMIC-IV Database - Scorecard - MDSpire

Association of Vitamin C with Enhanced Prognosis in Patients Experiencing Myocardial Injury Due to Sepsis: Findings from the MIMIC-IV Database

  • By

  • Rui Gong

  • Zifeng Huang

  • Jinyi Zhao

  • Meng Tang

  • Fei Mu

  • Kexin Sun

  • Chen Cui

  • Zhen Yan

  • Jingwen Wang

  • December 24, 2025

  • 0 min

Share

Clinical Scorecard: Association of Vitamin C with Enhanced Prognosis in Patients Experiencing Myocardial Injury Due to Sepsis: Findings from the MIMIC-IV Database

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationAdult patients (≥ 18 years) diagnosed with sepsis and SIMI, defined by cTnT > 0.01 ng/mL.
Care Setting

Key Highlights

  • Add citations for mortality statistics and Vitamin C treatment outcomes.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider adjunctive therapies like Vitamin C for patients with VC deficiency, specifying dosage.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        High-dose intravenous Vitamin C (specify dosage) may be beneficial in patients with VC deficiency.

        Clinical Best Practices

        • Monitor for adverse events associated with Vitamin C administration, including specific metrics like renal function tests.

        References

        Original Source(s)

        Related Content